Insitro
AI in Healthcare
Overview
Insitro is an AI-driven drug discovery platform that uses machine learning and functional genomics to identify new therapeutic targets and predict drug response. It combines high-throughput screening, CRISPR-based perturbation data, and machine learning models to discover disease-relevant targets and biomarkers. Insitro is designed for pharmaceutical research teams needing AI-powered target identification and drug discovery pipelines.
- Pricing model
- Enterprise / custom quote
- Deployment
- SaaS (vendor-hosted)
- Regions served
- United States
- Categories
- Vertical application, Workflow orchestration, Biotechnology, Predictive / classical ML, AI in Healthcare, SaaS (vendor-hosted), Enterprise / custom quote
- Last updated
- 2 October 2026
- Published
- 2 October 2026
Use cases
Deployment options
Data sources & provenance
Where this information came from, how it was checked and when it was last looked at. “Last updated” records a change to the record — it does not mean the record was verified.
- Data quality
- Data quality: Editorially Reviewed
- Primary source
- insitro.com
- Sources cited
- 2
- Last reviewed
- 28 September 2026
- Last updated
- 2 October 2026
Spotted something out of date?
Anyone can suggest a correction — you don't need an account. An editor checks every suggestion against the sources before the record changes.